Social anxiety nasal spray safety trial ends early

NCT ID NCT05030350

Terminated Symptom relief Sponsor: VistaGen Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested the safety of a nasal spray called PH94B for people with social anxiety disorder. Participants used the spray up to 4 times a day for up to 12 months when feeling anxious. The trial was terminated early, so we don't have full results on its safety or effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PH94B nasal spray
What this could lead to: If successful, this could point toward a fast-acting, on-demand treatment for anxiety in social situations.
What could go wrong: The trial was terminated early, so results are incomplete. It is unclear if PH94B is safe or effective long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOCIAL ANXIETY DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

social phobia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOCIAL ANXIETY DISORDER

Contacts and locations

Locations

VistaGen Investigational Site

Watertown, Massachusetts, 02472, United States
VistaGen Investigational Site

New York, New York, 10128, United States
VistaGen Investigational Site

Bellevue, Washington, 98007, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.